ImmunoCellular Therapeutics, Ltd. (IMUC)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 02:19PM EDT
Loading interactive chart…
- PR Newswire
EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613. EOM613 is a peptide-nucleic acid-based broad spectrum immune regulating agent that acts on both key pro-inflammatory and anti-inflammatory cytokines with potential therapeutic utility in treating a variety of acute and chronic inflammatory conditions.
© 2024 Yahoo. All rights reserved.